Cargando…
Lanreotide and diazoxide have comparable effects on glucose levels in an elderly Japanese insulinoma patient: a case report
An insulinoma is a pancreatic neuroendocrine tumor that causes hypoglycemia. In the elderly, as surgery is not always possible, drugs are an important alternative. However, the effects of lanreotide on insulinomas have not yet been elucidated. We report the case of an 85-year-old Japanese woman who...
Autores principales: | Manaka, Tomoo, Hirai, Hiroyuki, Kusano, Yoshiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Association of Rural Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527614/ https://www.ncbi.nlm.nih.gov/pubmed/34707739 http://dx.doi.org/10.2185/jrm.2020-065 |
Ejemplares similares
-
Successful medical management of insulinoma with diazoxide for 27 years
por: Warren, Annabelle M, et al.
Publicado: (2020) -
A case of insulinoma effectively treated with low‐dose diazoxide
por: Yasuda, Atsushi, et al.
Publicado: (2020) -
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
por: Yamaoka, Keiko, et al.
Publicado: (2021) -
SAT-LB303 Severe Refractory Volume Overload With Diazoxide in the Treatment of Insulinoma
por: Pasha, Pouneh, et al.
Publicado: (2020) -
Calcium Stimulation Test for Insulinoma Localization in an End-stage Renal Disease Patient on Diazoxide
por: Kim, Stephanie, et al.
Publicado: (2020)